PROSPECTS AND OPPORTUNITIES
Modest growth likely over the forecast period amid prospect of further regulatory and legal review
Value sales of cough, cold and allergy (hay fever) remedies are forecast a modest increase through until 2030, with growth anticipated to be driven by combination products - cough, cold and allergy (hay fever) remedies, but moderated by slowed growth in decongestants and pharyngeal preparations, as consumers migrate cross-category thanks to regulatory changes to access over the review period. Remedies for coughs and colds are likely to be closely reviewed over the forecast period, as the efficacy of phenylephrine when taken orally is brought into question.
Government funding of Fexaclear has potential to reshape systemic antihistamine market
Within antihistamines/allergy remedies (systemic), Claratyne (Bayer; active ingredient: loratadine) has traditionally been more accessible and widely used due to its OTC availability and lower cost. However, Telfast (Opella; active ingredient: fexofenadine hydrochloride) has gained popularity in recent years, especially among people with more severe hay fever symptoms, despite being pricier and not always subsidised.
Cost-of-living pressures likely to drive cross-category competition and encourage consumer shift towards affordable alternatives and preventative health and wellness
Amid increasing inflation, higher consumer prices and sluggish wage growth in 2025, the retail landscape represents a competitive environment in New Zealand, in which every consumer dollar is harder won. Cough, cold and allergy (hay fever) remedies is likely to face mounting pressure from cost-of-living conscious consumer behaviour over the forecast period.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Cough, Cold and Allergy (Hay Fever) Remedies industry in New Zealand with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in New Zealand, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand?
- Which are the leading brands in Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand?
- How are products distributed in Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand?
- How has the regulatory and operating environment for Cough, Cold and Allergy (Hay Fever) Remedies changed in New Zealand?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Cough, Cold and Allergy (Hay Fever) Remedies
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand - Category analysis
KEY DATA FINDINGS
Combination products drive steady growth in 2025 as pseudoephedrine-containing products are back on pharmacy shelves
International players lead as regulatory shifts shake up brand dynamics within cough and cold remedies
Supermarkets leads distribution in 2025, with pharmacies set to leverage improved access to previously restricted medicines following regulatory changes
Modest growth likely over the forecast period amid prospect of further regulatory and legal review
Government funding of Fexaclear has potential to reshape systemic antihistamine market
Cost-of-living pressures likely to drive cross-category competition and encourage consumer shift towards affordable alternatives and preventative health and wellness
Consumer Health in New Zealand - Industry Overview
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for Consumer Health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Cough, Cold and Allergy (Hay Fever) Remedies
- Antihistamines/Allergy Remedies (Systemic)
-
- Paediatric Allergy Remedies
- Paediatric Cough/Cold Remedies
- Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
- Cough Remedies
-
- Nasal Sprays
- Oral Decongestants
- Inhalant Decongestants
- Decongestant Rubs
- Nasal Decongestant Drops
- Nasal Decongestant Plasters
- Medicated Confectionery
- Pharyngeal Preparations
Cough, Cold and Allergy (Hay Fever) Remedies
This is the aggregation of decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, antihistamines and paediatric cough, cold and allergy remedies.
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Cough, Cold and Allergy (Hay Fever) Remedies research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!